KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.80

Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping.

Carsten Denkert, Sivaramakrishna Rachakonda, Thomas Karn, Karsten Weber, Miguel Martin, Frederik Marmé, Michael Untch, Hervé Bonnefoi, Sung-Bae Kim, Sabine Seiler, Harry D Bear, Agnieszka K Witkiewicz, Seock-Ah Im, Angela DeMichele, Anika Pehl, Laura Van't Veer, Nicole McCarthy, Thorsten Stiewe, Paul Jank, Karen A Gelmon, José A García-Sáenz, Christina C Westhoff, Catherine M Kelly, Toralf Reimer, Bärbel Felder, Mireia Melé Olivé, Erik S Knudsen, Nicholas Turner, Federico Rojo, Wolfgang D Schmitt, Peter A Fasching, Julia Teply-Szymanski, Zhe Zhang, Masakazu Toi, Hope S Rugo, Michael Gnant, Andreas Makris, Johannes Holtschmidt, Valentina Nekljudova, Sibylle Loibl

Cancer Cell 43(2) 232-247.e4

PMID39933898
PMCID-
DOI10.1016/j.ccell.2025.01.002
发表日期2025-02-11
入排依据:While the record describes a human, randomized, phase III oncology trial, the abstract does not report the required survival, progression, recurrence, death, or related efficacy outcomes. It is a biomarker/prognostic analysis, not an efficacy report.
摘要

摘要

We evaluate therapy-induced molecular heterogeneity in longitudinal samples from high-risk, hormone-receptor positive/HER2-negative breast cancer patients with residual tumor after neoadjuvant chemotherapy from the Penelope-B trial (NCT01864746; EudraCT 2013-001040-62). Intrinsic subtypes are prognostic in pre-therapeutic (Tx) samples (n = 629, p < 0.0001) and post-Tx residual tumors (n = 782, p < 0.0001). After neoadjuvant chemotherapy, a shift of intrinsic subtypes is observed from pre-Tx luminal (Lum) B to post-Tx LumA, with reverse transition back to LumB in metastases. In a combined analysis of 540 paired pre-Tx and post-Tx samples, we identify five adaptive clusters (AC-1-5) based on transcriptomic changes before and after neoadjuvant chemotherapy. These AC-subtypes are prognostic beyond classical intrinsic subtyping, categorizing patients into groups with excellent prognosis (AC-1 and AC-2), poor prognosis (AC-3 and AC-4), and very poor prognosis (AC-5, enriched for basal-like subtype). Our analysis provides a basis for an extended molecular classification of breast cancer patients and improved identification of high-risk patient populations.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。